Associated Papers
The efficacy and safety of Apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis.
Liu JY et al.
International Journal of Clinical Oncology, 2020
Select a paper to view details